Susan Marquez

ORCID: 0000-0003-1183-8522
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Diet and metabolism studies
  • Cardiac Ischemia and Reperfusion
  • Organ Transplantation Techniques and Outcomes
  • 3D Printing in Biomedical Research
  • Clinical Nutrition and Gastroenterology
  • Innovative Microfluidic and Catalytic Techniques Innovation
  • Hydrogen's biological and therapeutic effects
  • Organ Donation and Transplantation
  • Microfluidic and Capillary Electrophoresis Applications
  • Reproductive tract infections research
  • Mitochondrial Function and Pathology
  • Mass Spectrometry Techniques and Applications
  • Erythrocyte Function and Pathophysiology
  • Neuroscience and Neural Engineering
  • Blood disorders and treatments
  • Preterm Birth and Chorioamnionitis
  • Anatomy and Medical Technology
  • Hematopoietic Stem Cell Transplantation
  • Genetic and Kidney Cyst Diseases
  • Renal and related cancers
  • Reproductive System and Pregnancy
  • Renal Diseases and Glomerulopathies

Inspire
2023-2024

Harvard University
2020-2024

Boston University
2023

Despite remarkable advances in Organ-on-a-chip (Organ Chip) microfluidic culture technology, recreating tissue-relevant physiological conditions, such as the region-specific oxygen concentrations, remains a formidable technical challenge, and analysis of tissue functions is commonly carried out using one analytical technique at time. Here, we describe two-channel Organ Chip devices fabricated from polydimethylsiloxane gas impermeable polycarbonate materials that are integrated with multiple...

10.1016/j.bios.2024.116683 article EN cc-by-nc Biosensors and Bioelectronics 2024-08-17

Drugs that induce reversible slowing of metabolic and physiological processes would have great value for organ preservation, especially organs with high susceptibility to hypoxia-reperfusion injury, such as the heart. Using whole-organism screening metabolism, mobility, development in Xenopus, we identified an existing drug, SNC80, rapidly reversibly slows biochemical activities while preserving cell tissue viability. Although SNC80 was developed a delta opioid receptor activator, discovered...

10.7554/elife.93796 article EN public-domain eLife 2024-02-06

Drugs that induce reversible slowing of metabolic and physiological processes would have great value for organ preservation, especially organs with high susceptibility to hypoxia-reperfusion injury, such as the heart. Using whole-organism screening metabolism, mobility, development in Xenopus , we identified an existing drug, SNC80, rapidly reversibly slows biochemical activities while preserving cell tissue viability. Although SNC80 was developed a delta opioid receptor activator,...

10.7554/elife.93796.1 preprint EN 2024-02-06

Drugs that induce reversible slowing of metabolic and physiological processes would have great value for organ preservation, especially organs with high susceptibility to hypoxia-reperfusion injury, such as the heart. Using whole-organism screening metabolism, mobility, development in Xenopus , we identified an existing drug, SNC80, rapidly reversibly slows biochemical activities while preserving cell tissue viability. Although SNC80 was developed a delta opioid receptor activator,...

10.7554/elife.93796.2 preprint EN 2024-08-08

Drugs that induce reversible slowing of metabolic and physiological processes would have great value for organ preservation, especially organs with high susceptibility to hypoxia-reperfusion injury, such as the heart. Using whole-organism screening metabolism, mobility, development in Xenopus , we identified an existing drug, SNC80, rapidly reversibly slows biochemical activities while preserving cell tissue viability. Although SNC80 was developed a delta opioid receptor activator,...

10.7554/elife.93796.3 article EN public-domain eLife 2024-09-24

ABSTRACT Drugs that induce reversible slowing of metabolic and physiological processes would have great value for organ preservation, especially organs with high susceptibility to hypoxia-reperfusion injury, such as the heart. Using whole-organism screening metabolism, mobility, development in Xenopus , we identified an existing drug, SNC80, rapidly reversibly slows biochemical activities while preserving cell tissue viability. Although SNC80 was developed a delta opioid receptor activator,...

10.1101/2023.02.27.530270 preprint EN bioRxiv (Cold Spring Harbor Laboratory) 2023-02-28

Abstract Study question What is the underlying cause of infertility associated with bacterial vaginosis (BV)? Summary answer We provide first evidence to suggest that BV-associated could be result sperm dysfunction induced by exposure poor cervical microbiome. known already Infertility a global health concern, impacting 186 million individuals worldwide. In 25% infertile couples remains unexplained. The complex interactions between host mucosal epithelium, microbiome, and other...

10.1093/humrep/dead093.019 article EN Human Reproduction 2023-06-01
Coming Soon ...